- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- January 2024
- 104 Pages
Global
From €3500EUR$3,929USD£3,035GBP
Dalfopristin is an antibiotic used to treat a variety of bacterial infections. It is a combination of two antibiotics, dalfopristin and quinupristin, which work together to inhibit bacterial growth. Dalfopristin is used to treat infections caused by Gram-positive bacteria, such as Staphylococcus aureus and Streptococcus pneumoniae. It is also used to treat infections caused by Gram-negative bacteria, such as Escherichia coli and Klebsiella pneumoniae. Dalfopristin is available in both oral and intravenous formulations.
The market for dalfopristin is relatively small, but it is growing as more infections become resistant to other antibiotics. The drug is used mainly in hospitals and other healthcare settings, but it is also available in some retail pharmacies.
Companies in the dalfopristin market include Pfizer, Merck, Sanofi, and GlaxoSmithKline. These companies produce and market the drug in various forms, including tablets, capsules, and injections. Show Less Read more